These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 29395333

  • 1. Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.
    Toro L, Barrientos V, León P, Rojas M, Gonzalez M, González-Ibáñez A, Illanes S, Sugikawa K, Abarzúa N, Bascuñán C, Arcos K, Fuentealba C, Tong AM, Elorza AA, Pinto ME, Alzamora R, Romero C, Michea L.
    Kidney Int; 2018 May; 93(5):1131-1141. PubMed ID: 29395333
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T.
    Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
    [Abstract] [Full Text] [Related]

  • 3. Plasma FGF23 levels increase rapidly after acute kidney injury.
    Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H.
    Kidney Int; 2013 Oct; 84(4):776-85. PubMed ID: 23657144
    [Abstract] [Full Text] [Related]

  • 4. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A, Durlacher K, Silver J, Naveh-Many T, Levi R.
    Am J Physiol Renal Physiol; 2016 Feb 01; 310(3):F217-21. PubMed ID: 26311115
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
    Daryadel A, Bettoni C, Haider T, Imenez Silva PH, Schnitzbauer U, Pastor-Arroyo EM, Wenger RH, Gassmann M, Wagner CA.
    Pflugers Arch; 2018 Oct 01; 470(10):1569-1582. PubMed ID: 29961920
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure.
    Pramong N, Gojaseni P, Suttipongkeat S, Kiattisunthorn K, Chittinandana A.
    Nephrology (Carlton); 2021 Feb 01; 26(2):126-133. PubMed ID: 32902010
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.
    Leaf DE, Christov M, Jüppner H, Siew E, Ikizler TA, Bian A, Chen G, Sabbisetti VS, Bonventre JV, Cai X, Wolf M, Waikar SS.
    Kidney Int; 2016 Apr 01; 89(4):939-48. PubMed ID: 26924052
    [Abstract] [Full Text] [Related]

  • 8. Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.
    Mace ML, Gravesen E, Nordholm A, Hofman-Bang J, Secher T, Olgaard K, Lewin E.
    Kidney Int; 2017 Jul 01; 92(1):165-178. PubMed ID: 28341272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute blood loss stimulates fibroblast growth factor 23 production.
    Rabadi S, Udo I, Leaf DE, Waikar SS, Christov M.
    Am J Physiol Renal Physiol; 2018 Jan 01; 314(1):F132-F139. PubMed ID: 28877877
    [Abstract] [Full Text] [Related]

  • 11. Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome.
    Hanudel MR, Zinter MS, Chen L, Gala K, Lim M, Guglielmo M, Deshmukh T, Vangala S, Matthay M, Sapru A.
    PLoS One; 2019 Jan 01; 14(9):e0222065. PubMed ID: 31487315
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast Growth Factor 23 and Klotho in AKI.
    Christov M, Neyra JA, Gupta S, Leaf DE.
    Semin Nephrol; 2019 Jan 01; 39(1):57-75. PubMed ID: 30606408
    [Abstract] [Full Text] [Related]

  • 13. Extra-Large Gα Protein (XLαs) Deficiency Causes Severe Adenine-Induced Renal Injury with Massive FGF23 Elevation.
    Matthias J, Cui Q, Shumate LT, Plagge A, He Q, Bastepe M.
    Endocrinology; 2020 Jan 01; 161(1):. PubMed ID: 31758181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Erythropoietin modulates macrophages but not post-ischemic acute kidney injury in mice.
    Chou YH, Liao FL, Chen YT, Yeh PY, Liu CH, Shih HM, Chang FC, Chiang WC, Chu TS, Lin SL.
    J Formos Med Assoc; 2019 Jan 01; 118(1 Pt 3):494-503. PubMed ID: 30414800
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research.
    van Vuren AJ, Gaillard CAJM, Eisenga MF, van Wijk R, van Beers EJ.
    Front Physiol; 2019 Jan 01; 10():304. PubMed ID: 30971944
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation.
    Heitrich M, García DM, Stoyanoff TR, Rodríguez JP, Todaro JS, Aguirre MV.
    Biomed Pharmacother; 2016 Aug 01; 82():606-13. PubMed ID: 27470403
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients.
    de Oliveira Neves FM, Araújo CB, de Freitas DF, Arruda BFT, de Macêdo Filho LJM, Salles VB, Meneses GC, Martins AMC, Libório AB.
    J Transl Med; 2019 Apr 11; 17(1):121. PubMed ID: 30971270
    [Abstract] [Full Text] [Related]

  • 20. Pathogenic role of Fgf23 in Hyp mice.
    Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD.
    Am J Physiol Endocrinol Metab; 2006 Jul 11; 291(1):E38-49. PubMed ID: 16449303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.